Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Knowing when long term capital gains apply is vital for optimizing your investment outcomes. Understand your tax benefits to enhance your strategy.
27,839 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
A clear, actionable look at beyond (xair) 2026 earnings and what a Q4 earnings call could reveal. Learn how to read t...
SpaceX is the darling of space dreams and bold tech bets. This article breaks down what it would take for a public Sp...
As AI and data demand surge, investors eye NuScale Power and the small modular reactor trend. Can nuscale power next ...
Bridgewater Associates exits its Salesforce stake, prompting a broader discussion on how patient capital should value...
Hedge funds buying amazon can hint at value in a complex market. This guide breaks down what the trend may mean for y...
Markets swing, but smart investors seek durable growth. This article highlights three names with a credible path to m...
Major indices surge as news of a potential Iran peace framework reduces geopolitical risk. Oil slides below $100, eas...
A stronger-than-expected May jobs report masks deeper tensions. Three warnings from analysts lay out the hidden risks...
Veteran market commentator Jim Cramer signaled a shift to caution, saying funds are drying up for big tech deals. The...
A growing spotlight on disabled adult child benefits is reshaping family planning. DAC payments, typically about half...
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...